Regionalization of care for acute coronary syndromes: More evidence is needed

JAMA

Volumn 293, Issue 11, 2005, Pages 1383-1387

  Rathore, Saif S ^a   Epstein, Andrew J ^c   Volpp, Kevin G M ^e,f   Krumholz, Harlan M ^a,b,c,d  

^a Section of Cardiovascular Medicine   (United States)

^b Robert Wood Johnson Clinical Scholars Program   (United States)

^c Section of Health Policy and Administration   (United States)

^d YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF PENNSYLVANIA   (United States)

^f Vet Aff Ctr Hlth Equity Res P   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; FIBRINOLYTIC AGENT; HEPARIN;

ACUTE CORONARY SYNDROME; CLINICAL TRIAL; EVIDENCE BASED MEDICINE; FIBRINOLYTIC THERAPY; HEALTH CARE FACILITY; HEALTH CARE QUALITY; HEALTH ECONOMICS; HEALTH HAZARD; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; HOSPITAL ADMISSION; HOSPITAL CARE; HUMAN; MEDICAL SPECIALIST; NOTE; PATIENT TRANSPORT; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; REGIONALIZATION; STROKE; ACUTE DISEASE; ARTICLE; CORONARY ARTERY DISEASE; HEALTH CARE PLANNING; HOSPITAL SUBDIVISIONS AND COMPONENTS; UNITED STATES;

ACUTE DISEASE; CORONARY DISEASE; HOSPITAL UNITS; HUMANS; PATIENT TRANSFER; QUALITY OF HEALTH CARE; REGIONAL HEALTH PLANNING; UNITED STATES;

EID: 14844299407     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.293.11.1383     Document Type: Note

References (40)

1. Califf RM, Faxon DP. Need for centers to care for patients with acute coronary syndromes. Circulation. 2003;107:1467-1470.
2. Topol EJ, Kereiakes DJ. Regionalization of care for acute ischemic heart disease: a call for specialized centers. Circulation. 2003;107:1463-1466.
3. Williams DO. Treatment delayed is treatment denied. Circulation 2004;109:1806-1808.
4. Andersen HR, Nielsen TT, Rasmussen K, et al. A comparison of coronary angioplasty with fibrinolytic therapy in acute myocardial infarction. N Engl J Med. 2003;349:733-742.
5. Widimsky P, Groch L, Zelizko M, et al. Multicentre randomized trial comparing transport to primary angioplasty vs immediate thrombolysis vs combined strategy for patients with acute myocardial infarction presenting to a community hospital without a catheterization laboratory. Eur Heart J. 2000;21:823-831.
6. Widimsky P, Budesinsky T, Vorac D, et al. Long-distance transport for primary angioplasty vs immediate thrombolysis in acute myocardial infarction: final results of the randomized national multicentre trial-PRAGUE-2. Eur Heart J. 2003;24:94-104.
7. Grines CL, Westerhausen DR, Grines LL, et al. A randomized trial of transfer for primary angioplasty verus on-site thrombolysis in patients with high-risk myocardial infarction: the Air Primary Angioplasty in Myocardial Infarction Study. J Am Coll Cardiol. 2002;39:1713-1719.
8. Vermeer F, Ophuis AJ, Berg EJ, et al. Prospective randomized comparison between thrombolysis, rescue PTCA, and primary PTCA in patients with extensive myocardial infarction admitted to a hospital without PTCA facilities: a safety and feasibility study. Heart. 1999;82:426-431.
9. Dalby M, Bouzamondo A, Lechat P, Montalescot G. Transfer for primary angioplasty versus immediate thrombolysis in acute myocardial infarction: a meta-analysis. Circulation. 2003;108:1809-1814.
10. Armstrong PW, Antman EM. Coronary angioplasty versus fibrinolytic therapy in acute myocardial infarction. N Engl J Med. 2003;349:2168.
11. Keeley EC, Boura JA, Grines CL. Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials. Lancet. 2003;361:13-20.
12. Steg PG, Bonnefoy E, Chabaud S, et al. Impact of time to treatment on mortality after prehospital fibrinolysis or primary angioplasty: data from the CAPTIM randomized clinical trial. Circulation. 2003;108:2851-2856.
13. Kent DM, Schmid CH, Lau J, Selker HP. Is primary angioplasty for some as good as primary angioplasty for all? modeling across trials and individual patients. J Gen Intern Med. 2002;17:887-894.
14. Cannon CP, Weintraub WS, Demopoulos LA, et al. Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with glyocoprotein IIb/IIIa inhibitor tirofiban. N Engl J Med. 2001;344:1879-1887.
15. Bogaty P, Brophy J. Increasing burden of treatment in the acute coronary syndromes: is it justified? Lancet. 2003;361:1813-1816.
16. Thiemann DR, Coresh J, Oetgen WJ, Powe NR. The association between hospital volume and survival after acute myocardial infarction in elderly patients. N Engl J Med. 1999;340:1640-1648.
17. Canto JG, Every NR, Magid DJ, et al. The volume of primary angioplasty procedures and survival after acute myocardial infarction. N Engl J Med. 2000;342:1573-1580.
18. Shahian DM, Normand SL. The volume-outcome relationship: from Luft to Leapfrog. Ann Thorac Surg. 2003;75:1048-1058.
19. Ho V. Evolution of the volume-outcome relation for hospitals performing coronary angioplasty. Circulation. 2000;101;1806-1811.
20. Epstein AJ, Rathore SS, Volpp KGM, Krumholz HM. Hospital percutaneous coronary intervention volume and patient mortality, 1998 to 2000: does the evidence support current procedure volume minimums? J Am Coll Cardiol. 2004;43: 1755-1762.
21. McClellan M, McNeil BJ, Newhouse JP. Does more intensive treatment of acute myocardial infarction in the elderly reduce mortality? analysis using instrumental variables. JAMA. 1994;272:859-866.
22. Fisher ES, Wennberg DE, Stukel TA, Gottlieb DJ, Lucas FL, Pinder EL. The implications of regional variations in Medicare spending, part 2: health outcomes and satisfaction with care. Ann Intern Med. 2003;138:288-298.
23. Stukel TA, Lucas FL, Wennberg DE. Long-term outcomes of regional variations in intensity of invasive vs medical management of Medicare patients with acute myocardial infarction. JAMA. 2005;293:1329-1337.
24. Jollis JG, DeLong ER, Peterson ED, et al. Outcome of acute myocardial infarction according to the specialty of the admitting physician. N Engl J Med. 1996;335: 1880-1887.
25. Go AS, Rao RK, Dauterman KW, Massie BM. A systematic review of the effects of physican specialty on the treatment of coronary disease and heart failure in the United States. Am J Med. 2000;108:216-226.
26. Frances CD, Go AS, Dauterman KW, et al. Outcome following acute myocardial infarction: are differences among physician specialties the result of quality of care or case mix? Circulation. 1999;159:1429-1436.
27. Ayanian JZ, Landrum MB, Guadagnoli E, Gaccione P. Specialty of ambulatory care physicians and mortality among elderly patients after myocardial infarction. N Engl J Med. 2002;347:1678-1686.
28. Nallamothu BK, Bates ER, Herrin J, et al. Times to treatment in transfer patients undergoing primary percutaneous coronary intervention in the United States: National Registry of Myocardial Infarction (NRMI) 3/4 analysis. Circulation. In press.
29. Nallamothu BK, Bates ER. Percutaneous coronary intervention versus fibrinolytic therapy in acute myocardial infarction: is timing (almost) everything? Am J Cardiol. 2003;92:824-826.
30. Gibson CM, de Lemos JA, Antman EM; TIMI Study Group. Time is muscle in primary PCI: the strength of the evidence grows. Eur Heart J. 2004;25:1001-1002.
31. Keeley EC, Grines CL. Primary percutaneous coronary intervention for every patient with ST-segment elevation myocardial infarction: what stands in the way? Ann Intern Med. 2004;141:298-304.
32. Chen J, Radford MJ, Wang Y, Marciniak TA, Krumholz HM. Do "America's best hospitals" perform better for acute myocardial infarction? N Engl J Med. 1999; 340:286-292.
33. Agency for Healthcare Research and Quality. Healthcare cost and utilization project. Available at: http://www.ahrq.gov/data/hcup/hcupnet.htm. Accessed May 12, 2003.
34. Kansagra SM, Curtis LH, Schulman KA. Regionalization of percutaneous transluminal coronary angioplasty and implications for patient travel distance. JAMA. 2004;292:1717-1723.
35. National Heart Attack Alert Program Coordinating Committee Access to Care Subcommittee. Access to timely and optimal care of patients with acute coronary syndromes-community planning considerations: a report by the National Heart Attack Alert Program. J Thromb Thrombolysis. 1998;6:19-46.
36. Pope JH, Aufderheide TP, Ruthazer R, et al. Missed diagnoses of acute cardiac ischemia in the emergency department. N Engl J Med. 2000;342:1163-1170.
37. General Accounting Office. Specialty Hospitals: Information on National Market Share, Physician Ownership, and Patients Served. Washington, DC: General Accounting Office; 2003. Publication GAO-03-683R.
38. Devers KJ, Brewster LR, Ginsburg PB. Specialty Hospitals: Focused Factories or Cream Skimmers? Washington, DC: Center for Studying Health System Change; 2003.
39. Ho V. Learning and the evolution of medical technologies: the diffusion of coronary angioplasty. J Health Econ. 2002;21:873-885.
40. Eagle KA, Goodman SG, Avezum A, et al. Practice variation and missed opportunities for reperfusion in ST-segment elevation myocardial infarction: findings from the Global Registry of Acute Coronary Events (GRACE). Lancet. 2002; 359:373-377.